Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 264

    1.

    Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats.

    Cruzado JM, Lloberas N, Torras J, Riera M, Fillat C, Herrero-Fresneda I, Aran JM, Alperovich G, Vidal A, Grinyó JM.

    Diabetes. 2004 Apr;53(4):1119-27.PMID: 15047630 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.

    Makino H, Mukoyama M, Sugawara A, Mori K, Suganami T, Yahata K, Fujinaga Y, Yokoi H, Tanaka I, Nakao K.

    Clin Exp Nephrol. 2003 Mar;7(1):33-40.PMID: 14586741 [PubMed - indexed for MEDLINE]Related articles

    3.

    Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.

    Mizuno S, Nakamura T.

    Am J Physiol Renal Physiol. 2004 Jan;286(1):F134-43. Epub 2003 Sep 30.PMID: 14519594 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.

    Dai C, Yang J, Bastacky S, Xia J, Li Y, Liu Y.

    J Am Soc Nephrol. 2004 Oct;15(10):2637-47.PMID: 15466268 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.

    Wang SN, LaPage J, Hirschberg R.

    Kidney Int. 2000 Mar;57(3):1002-14.PMID: 10720953 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.

    Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX.

    Diabetes. 2006 Jun;55(6):1678-85.PMID: 16731830 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice.

    Kagawa T, Takemura G, Kosai K, Murata I, Ohno T, Takahashi T, Esaki M, Maruyama R, Fujiwara T, Ohashi H, Fujiwara H.

    Nephron Physiol. 2006;102(3-4):p92-102. Epub 2005 Dec 6.PMID: 16340242 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats.

    Long X, Xiong SD, Xiong WN, Xu YJ.

    Chin Med J (Engl). 2007 Aug 20;120(16):1432-7.PMID: 17825173 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.

    Wang SN, Hirschberg R.

    Am J Physiol Renal Physiol. 2000 Apr;278(4):F554-60.PMID: 10751215 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease.

    Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME, Kantharidis P.

    J Am Soc Nephrol. 2006 Sep;17(9):2484-94. Epub 2006 Aug 16.PMID: 16914537 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.

    Kelly DJ, Gilbert RE, Cox AJ, Soulis T, Jerums G, Cooper ME.

    J Am Soc Nephrol. 2001 Oct;12(10):2098-107.PMID: 11562408 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

    Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

    13.

    Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

    Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

    Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.

    Mifsud S, Kelly DJ, Qi W, Zhang Y, Pollock CA, Wilkinson-Berka JL, Gilbert RE.

    Nephron Physiol. 2003;95(4):p83-91.PMID: 14694265 [PubMed - indexed for MEDLINE]Related articles

    15.

    Mechanisms through which bradykinin promotes glomerular injury in diabetes.

    Tan Y, Wang B, Keum JS, Jaffa AA.

    Am J Physiol Renal Physiol. 2005 Mar;288(3):F483-92.PMID: 15692059 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.

    Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM.

    Diabetologia. 2005 Dec;48(12):2650-60. Epub 2005 Nov 4.PMID: 16270194 [PubMed - indexed for MEDLINE]Related articles

    17.

    Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.

    Chen S, Jim B, Ziyadeh FN.

    Semin Nephrol. 2003 Nov;23(6):532-43. Review.PMID: 14631561 [PubMed - indexed for MEDLINE]Related articles

    18.

    Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.

    Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB.

    Kidney Int. 2005 May;67(5):1762-71.PMID: 15840023 [PubMed - indexed for MEDLINE]Related articles

    19.

    The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.

    Gojo A, Utsunomiya K, Taniguchi K, Yokota T, Ishizawa S, Kanazawa Y, Kurata H, Tajima N.

    Eur J Pharmacol. 2007 Jul 30;568(1-3):242-7. Epub 2007 Apr 20.PMID: 17511984 [PubMed - indexed for MEDLINE]Related articles

    20.

    Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes.

    Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T.

    Circulation. 2001 Nov 6;104(19):2344-50.PMID: 11696476 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data